✦ LIBER ✦

Phase II study of low-dose weekly paclitaxel as second-line treatment for advanced non-small cell lung cancer

✍ Scribed by O. Juan; V. Alberola; A. Rocher; R. Casany; V. Carañana; J.M. Campos; A. Albert; V. Alberola Jr.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of weekly paclitaxel as s

✍ Ceresoli, Giovanni Luca; Gregorc, Vanesa; Cordio, Stefano; Bencardino, Katia Bru 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Phase II study of weekly chemotherapy wi

✍ Kiyoshi Mori; Yukari Kamiyama; Tetsuro Kondo; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 330 KB

Phase II study of weekly plitidepsin as

✍ Eisen, Tim; Thatcher, Nick; Leyvraz, Serge; Miller, Wilson H.; Couture, Felix; L 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Second line treatment of antiangiogenic

✍ Stani, Simonetta Chiara; Sarmiento, Roberta; Mansueto, Giovanni; Bonginelli, Pao 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB

A phase II study of S-1 monotherapy as s

✍ Yoshitaka Totani; Yuji Saito; Masamichi Hayashi; Toshihiko Tada; Yasuo Kohashi; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 261 KB

Phase II study of weekly gemcitabine in

✍ M. Halme; A. Jekunen; K. Tamminen; K. Mattson 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 437 KB